Bloomberg

Bloomberg
Share

Bloomberg

 •  June 28

(Bloomberg) -- In the wake of mounting overdoses and deaths from the opioid-addiction crisis sweeping across the U.S., drugmakers are racing to come up with safer painkillers. Companies are highly motivated to create alternatives to the $4 billion opioid market. The federal government is cracking down on lax prescriptions that contribute to many...

Bloomberg

 •  June 9

(Bloomberg) -- Amid an outbreak of dangerous infections by pain drug abusers, the U.S. Food and Drug Administration has asked Endo International Plc to stop sales of its powerful opioid painkiller Opana ER, the first time the agency has taken such a step. While the drug was approved by the FDA for legitimate pain relief, it’s become a favorite of...

Bloomberg

 •  May 9

(Bloomberg) -- The pharmaceutical industry’s powerful Washington trade association fell in size by almost two dozen companies after revising membership rules amid the debate over U.S. drug prices. Pharmaceutical Research and Manufacturers of America, or PhRMA, will require that members spend at least $200 million a year on research and development...

Bloomberg

 •  February 16

(Bloomberg) -- Drugmaker Stada Arzneimittel AG got a third suitor as potential buyers vie for its business in Germany and Russia. The company said Thursday it’s received a non-binding offer at 58 euros a share -- which gives it a value of about $3.85 billion -- and is now weighing its options among three potential buyers. It didn’t identify the...